Intelligent Ultrasound Group PLC Launch of ScanNav FetalCheck and its use in study (3853U)
November 23 2023 - 1:00AM
UK Regulatory
TIDMIUG
RNS Number : 3853U
Intelligent Ultrasound Group PLC
23 November 2023
Intelligent Ultrasound announces launch of new gestational age
estimation AI software, ScanNav FetalCheck and its use in first
field study
PRESS RELEASE 23 November 2023: Intelligent Ultrasound Group plc
(AIM: IUG), the 'classroom to clinic' ultrasound company
specialising in artificial intelligence (AI) software and
simulation, is pleased to announce a new AI development programme
for gestational age estimation in prenatal care. ScanNav FetalCheck
scanning technology aims to enable a non-skilled or skilled user to
establish the gestational age (GA) accurately with minimal
training.
Pregnant women are usually offered two routine ultrasound scans.
The first at 11-14 weeks is performed to confirm viability of the
fetus as well as the gestational age to pinpoint the likely due
date. A second scan at 18-20 weeks focusses on detecting congenital
abnormalities. Additional scans may be offered to monitor high-risk
or complex pregnancies.
Having an accurate gestational age is important in the
management of pregnancy, both to assess fetal growth and to inform
treatment choice in the event that complications are seen. However,
accurate determination of GA is difficult in low and middle -income
countries (LMICs) as, currently, GA must be measured by trained
sonographers, and very few front-line healthcare workers have the
necessary skills.
Intelligent Ultrasound's ScanNav FetalCheck software aims to
enable a non-skilled user to get an accurate GA with minimal
training and without the need for an expensive high-end ultrasound
machine. It has the potential to transform antenatal care both in
LMICs and in high income countries (HICs) by allowing the age of
the fetus to be assessed in a primary care setting where women need
it.
Intelligent Ultrasound is also pleased to announce that a
leading university in Africa has purchased four ScanNav FetalCheck
systems as part of a trial to evaluate biomarkers and other factors
which affect the probability of stillbirth.
ScanNav FetalCheck is currently not licenced for clinical
use.
Aris Papageorghiou, Professor of fetal medicine at the
University of Oxford said:
"Accurate estimation of gestational age is crucial for prenatal
care: all aspects depend on knowledge of how far along the
pregnancy journey a woman and her fetus are. In many low-income
settings this is just not available, chiefly due to unavailability
of expensive ultrasound equipment and trained staff. In this
project, hand-held ultrasound and AI technology are being paired to
overcome these roadblocks - this is disruptive technology that has
the potential to allow better pregnancy care for all women."
Nicholas Sleep, COO at Intelligent Ultrasound said:
"The use of ScanNav FetalCheck in this first field study is a
testament to the ease of use of our new AI software. Our mission is
to make ultrasound easier to learn and simpler to use. This is the
next step on our journey to achieving this and putting ultrasound
into the hands of front-line health practitioners."
ENDS
Enquiries:
Intelligent Ultrasound Group plc www.intelligentultrasound.com
Stuart Gall, CEO Tel: +44 (0)29 2075 6534
Helen Jones, CFO
Cavendish Securities Plc
(Nominated advisor and broker)
Giles Balleny (Corporate Finance) Tel: +44 (0)20 7397 8900
Nigel Birks (ECM)
Dale Bellis (Sales)
TB Cardew - PR Advisors Intelligentultrasound@tbcardew.com
Ed Orlebar Tel: +44 (0)7738 724630
Allison Connolly Tel: +44 (0)7587 453955
Emma Pascoe-Watson Tel: +44 (0)7774 620415
Jessica Pilling Tel: +44 (0)7918 584573
About Intelligent Ultrasound Group
Intelligent Ultrasound (AIM: IUG) is one of the world's leading
'classroom to clinic' ultrasound companies, specialising in
real-time hi-fidelity virtual reality simulation for the ultrasound
training market ('classroom') and artificial intelligence-based
clinical image analysis software tools for the diagnostic medical
ultrasound market ('clinic'). Based in Cardiff in the UK and
Atlanta in the US, the Group has two revenue streams:
Simulation
Real-time hi-fidelity ultrasound education and training through
simulation. Our main products are the ScanTrainer obstetrics and
gynaecology training simulator, the HeartWorks echocardiography
training simulator, the BodyWorks Eve Point of Care and Emergency
Medicine training simulator with Covid-19 module and the new
BabyWorks Neonate and Paediatric training simulator. To date over
1,500 simulators have been sold to over 750 medical institutions
around the world.
Clinical AI software
Deep learning-based algorithms to make ultrasound machines
smarter and more accessible using our proprietary ScanNav
ultrasound image analysis technology. Current products on the
market utilising this technology are GE HealthCare's SonoLyst
software that is incorporated in their Voluson Expert 22 and SWIFT
ultrasound machines; ScanNav Anatomy PNB that simplifies
ultrasound-guided needling by providing the user with real-time
AI-based
anatomy highlighting for a range of medical procedures; and NeedleTrainer that teaches real-time ultrasound-guided needling and incorporates ScanNav Anatomy PNB.
www.intelligentultrasound.com
NOTE: ScanNav Anatomy PNB is CE approved and cleared for sale in
the US by the FDA, but is not available for sale in any other
territory requiring government approval for this type of
product.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
PRLBTBPTMTMTBAJ
(END) Dow Jones Newswires
November 23, 2023 02:00 ET (07:00 GMT)
Intelligent Ultrasound (LSE:IUG)
Historical Stock Chart
From Aug 2024 to Sep 2024
Intelligent Ultrasound (LSE:IUG)
Historical Stock Chart
From Sep 2023 to Sep 2024